Correction: Wang et al. Immune Persistence Following a Single Dose of Varicella Vaccine: 5-Year and 8-Year Follow-Up of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial. Vaccines 2025, 13, 1024
Yanxia Wang, Xiangling Lei, Lili Huang, Yuehong Ma, Hongxue Yuan, Dongyang Zhao, Fanhong Meng
Abstract
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHerpesvirus Infections and Treatments · Bacterial Infections and Vaccines · Multiple Sclerosis Research Studies
There was an error in the original publication [1]. In the Materials and Methods, Section 2.3 “Vaccines”, the potency of the varicella vaccine (VarV) was mistakenly reported as “approximately 2.2 lgPFU per dose (0.5 mL)”, which does not reflect the release specification of the investigational product used in this study. Therefore, the sentence “The potency of the VarV was approximately 2.2 lgPFU per dose (0.5 mL)” should be corrected to “The potency of the VarV was not less than 3.3 lgPFU per dose (0.5 mL).”
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.